Erin Borger
Director Ejecutivo en ExThera Medical Corp. .
Cargos activos de Erin Borger
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | 15/11/2023 | - |
Historial de carrera de Erin Borger
Antiguos cargos conocidos de Erin Borger.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| LONGEVERON INC. | Director/Miembro de la Junta | 12/02/2021 | 09/06/2023 |
| Independent Dir/Board Member | 12/02/2021 | 09/06/2023 | |
| National Parkinson Foundation, Inc. | Director/Miembro de la Junta | 12/01/2014 | - |
Formación de Erin Borger.
| Wofford College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Director/Board Member | 3 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| LONGEVERON INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
| National Parkinson Foundation, Inc. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Bolsa de valores
- Insiders
- Erin Borger
- Experiencia
